
The UK must ensure global equitable access to the HIV treatment lenacapavir
The NHS has announced access to the HIV drug lenacapavir in England, but campaigners warn that global access remains unequal. Despite clinical trials in countries like Brazil and Mexico, high costs prevent widespread availability, prompting calls for UK diplomatic action.

















